Increasing Incidence of Human Melioidosis in Northeast Thailand by Limmathurotsakul, Direk et al.
1113
Am. J. Trop. Med. Hyg., 82(6), 2010, pp. 1113–1117
doi:10.4269/ajtmh.2010.10-0038
Copyright © 2010 by The American Society of Tropical Medicine and Hygiene
     INTRODUCTION 
  Melioidosis is a severe community-acquired infectious dis-
ease caused by the Gram-negative bacillus   Burkholderia 
pseudomallei  . This organism is present in the environment in 
a defined geographic distribution, and infection is acquired 
through bacterial inoculation or contamination of wounds, 
inhalation, and ingestion.  1   Melioidosis is most frequently 
reported from northeast Thailand where it is the most common 
cause of community-acquired bacteremia,  2   and from Darwin, 
northern Australia where it is the most common cause of fatal 
community-acquired septicemic pneumonia.  3   Melioidosis also 
occurs across much of South and East Asia and parts of South 
America;  4,  5   infection may be grossly underreported in these 
areas, because diagnostic confirmation relies on a microbio-
logical culture that is often unavailable in resource-restricted 
regions of the world. Infection in adulthood usually occurs in 
people with one or more pre-disposing factors, and the stron-
gest risk factor is diabetes mellitus.  2,  6   Overall mortality has 
been reported to be 50% in northeast Thailand and 19% in 
Australia,  7,  8   a difference most likely caused by the inequity in 
availability of intensive-care facilities.  9  
  A previous study performed in northeast Thailand reported 
the incidence of melioidosis to be relatively constant at 4.4 per 
100,000 people per year (95% confidence interval [CI] = 3.8–
5.0) between 1987 and 1991.  2   This is low compared with the 
recently reported incidence rates of 19.6 and 20.0 per 100,000 
people per year in northern Australia and Papua New Guinea, 
respectively.  6,  10   The study reported here was undertaken in 
response to growing suspicions among clinicians and research-
ers in northeast Thailand that the incidence of melioidosis is 
increasing over time. Our objectives were to recalculate the 
incidence rate of melioidosis in this region, evaluate factors 
associated with the varying incidence rate, and compare the 
rate of death from melioidosis with other infectious diseases 
in our population. 
   MATERIALS AND  METHODS 
  Study  site.     Northeast Thailand has a population of 
21.4 million (Department of Provincial Administration, 
Thailand, unpublished data), and it consists of 19 provinces 
and covers 170,226 km  2  . Ubon Ratchathani is the largest prov-
ince in northeast Thailand with a population of 1.8 million, 
covers 16,112 km  2  , and is bordered by Cambodia to the south 
and Laos to the east. Sappasithiprasong Hospital, the largest 
hospital in the province and a referral center for 25 community 
hospitals, served as the study site. This is the major referral 
center in the province for cases of melioidosis. 
   Identification  of  study  population.    We  undertook  active 
surveillance to identify all patients presenting to Sappa-
sithiprasong Hospital with melioidosis between January 1, 1997 
and December 31, 2006 as part of clinical trials conducted at 
this study site. The hospital diagnostic laboratory was contacted 
daily to identify patients with one or more cultures positive 
for   B. pseudomallei  . Rounds of the medical and intensive-
care wards were conducted daily to identify additional cases. 
Any patients not already known to us who were suspected 
of having melioidosis based on presenting clinical features 
had samples taken for culture, including blood, throat swab, 
sputum (or tracheal aspirate), pus and surface swab from 
wounds and skin lesions. All patients with microbiologically 
confirmed melioidosis were visited daily to obtain informa-
tion on history, examination findings, and outcome, which 
was defined as survival to discharge or in-hospital death. A 
minority of relatives take moribund patients home from this 
hospital to die, and these cases were assumed to have died. 
Ethical permission for all clinical trials was obtained from 
the Ethical and Scientific Review Subcommittee of the Thai 
Ministry of Public Health.  11–  14  
   Data  analyses.     Patient data used in this study were age, 
gender, presence of diabetes mellitus, and death. Patients with 
diabetes were categorized into two groups: (1) the patient had 
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a pre-existing history of diabetes, or (2) the patient did not 
have a history of diabetes but had hyperglycemia at the time of 
admission with melioidosis. The latter group contained patients 
that survived to discharge and were confirmed as new diabetics, 
and those that died before diabetes could be confirmed or 
refuted. Patients who had acute hyperglycemia at presentation 
that survived and were not diabetic on subsequent testing were 
classified as non-diabetics. Hemoglobin A1c values   were not 
available. The Third National Health Examination Survey 2004 
was used to obtain estimates on the prevalence of diagnosed 
and undiagnosed diabetes in the Thai population.  15   Population 
data by age and sex for Ubon Rathchathani province for 
the years 1997–2006 were obtained from the Department 
of Provincial Administration, Thailand. The overall, age-
stratified, and sex-stratified annual incidences of melioidosis 
in Ubon Ratchathani province were calculated as the number 
of culture-confirmed cases identified at Sappasithiprasong 
Hospital per 100,000 people. The annual population mortality 
rate from melioidosis in Ubon Ratchathani province was 
calculated as the number of patients with melioidosis who 
died at Sappasithiprasong Hospital per 100,000 people. Data 
on population mortality rates for other infectious diseases in 
Thailand were obtained from the Ministry of Public Health.  16  
Data on annual rainfall in Ubon Ratchathani in the years 
1997–2006 were obtained from the Thai Meteorological 
Department. Univariable and multivariable Poisson regression 
models were used to calculate crude and adjusted rate ratios. 
CIs were calculated using the Poisson method. The Spearman 
correlation coefficient was used to evaluate the association 
between the incidence of melioidosis and annual rainfall. 
A χ  2   test for trend was used to assess change in proportion 
over time. All analyses were performed using STATA version 
10.1 (Stata Corp., College Station, TX). 
    RESULTS 
  Incidence  of  melioidosis.     A total of 2,243 patients were 
admitted to Sappasithiprasong Hospital between 1997 and 
2006 with their first episode of culture-confirmed melioidosis. 
Overall, 24% of cases were diagnosed as a result of active case 
finding on the medical and intensive-care wards. The average 
annual incidence rate for the province during the 10-year study 
period was 12.7 cases per 100,000 people per year, but the rate 
showed considerable variability over time (  Table 1  ). A year-
on-year increase was observed between 2000 and 2006, and an 
annual incidence (100,000 people) of 8.0 (95% CI = 7.2–10.0) 
in 2000 rose to 21.3 (95% CI = 19.2–23.6) in 2006 (  P   < 0.001; 
χ  2   test for trend). There was a negative association between 
the total annual rainfall and the number of melioidosis cases 
in each year (Spearman’s ρ = −0.89;   P   < 0.001) (  Table 1  ). 
        Incidence  of  melioidosis  by  age,  gender,  and  diabetes.  
  Twenty-seven patients were excluded from this analysis, 
because the history of underlying diseases was not recorded. 
Of the 2,217 patients remaining, 1,296 (58.5%) were male, 
and 921 (41.5%) were female. Median age was 49 years 
(interquartile range [IQR]   = 37–60 years), and 199 patients 
(9.0%) were younger than 15 years of age. A total of 662 
patients (29.9%) were patients with known diabetes, and 
an additional 370 patients (16.7%) were defined as having 
previously undiagnosed diabetes at presentation with melioi-
dosis. The previously undiagnosed diabetes group was made 
up of 222 patients (60%) who survived their episode of melioi-
dosis and had confirmed diabetes and 148 patients (40%) who 
were hyperglycemic at presentation but died of melioidosis 
before the presence of diabetes could be investigated.   Table 2   
shows the average annual incidence rate of melioidosis by age, 
sex, and presence of diabetes. Melioidosis was more common 
in males, and incidence was highest in the 55- to 64-year age 
group. Crude and adjusted rate ratios (RR) were calculated for 
gender, age, and diabetes (  Table 3  ). Male sex, age ≥ 45 years, 
and both known and undiagnosed diabetes were independent 
risk factors for melioidosis. Known and undiagnosed diabetes 
were associated with an adjusted RR of 12.4 and 7.8, respec-
tively, compared with no diabetes (  P   < 0.001). 
            Deaths  from  melioidosis.     Death occurred in 956 of 2,243 
patients, and the average mortality rate over the study period 
was 42.6% (  Table 1  ). There was a decrease in mortality rate 
over time from 49% in 1997 to 40.5% in 2006 (  P   = 0.006; 
χ  2   test for trend). The average mortality rate from melioidosis 
was calculated for the province as 5.41 per 100,000 people 
per year.   Figure 1   shows a comparison between these data 
and national population mortality rates attributed to other 
infectious diseases. If national data for deaths from infectious 
diseases are representative for Ubon Ratchathani province, 
melioidosis was the third most common cause of death from 
an infectious disease over the study period after human 
immunodeficiency virus (HIV)/acquired immunodeficiency 
syndrome (AIDS) and tuberculosis. In 2006, the population 
mortality rate attributed to melioidosis was comparable 
with the mortality rate attributed to tuberculosis (8.64 [95% 
CI = 7.33–10.11] versus 8.30 per 100,000 people per year, 
respectively). 
  Table  1 
    Incidence of melioidosis and associated death rate between 1997 and 2006   
Year
Average annual rainfall (mm) in 





1997 1,555.1 198 97 49.0% 11.53 5.65
1998 1,318.3 257 124 48.2% 14.85 7.16
1999 1,582.5 173 71 41.0% 9.83 4.04
2000 1,844.6 141 67 47.5% 7.98 3.79
2001 1,709.4 152 61 40.1% 8.54 3.43
2002 1,677.3 184 83 45.1% 10.26 4.63
2003 1,560.4 235 90 38.3% 13.02 4.99
2004 1,471.1 250 99 39.6% 14.18 5.62
2005 1,323.0 273 110 40.3% 15.38 6.20
2006 1,526.7 380 154 40.5% 21.31 8.64
    Spearman correlation coefficient between the number of patients and the level of annual rainfall = −0.89;   P   < 0.001.   1115 MELIOIDOSIS IN NORTHEAST THAILAND
     DISCUSSION 
  Our data suggest that melioidosis is the third most com-
mon cause of death from an infectious disease in our region 
after HIV/AIDS and tuberculosis. Deaths from melioidosis 
and tuberculosis were comparable in 2006, and melioidosis 
may become established as the second most common cause of 
death if the current trend of increasing melioidosis incidence 
is sustained. The population mortality rate for melioidosis is 
more than from malaria and diarrheal illness combined in this 
setting, diseases that are usually considered to be of high pri-
ority by funding agencies and global health organizations. We 
propose that the number of cases and deaths from melioidosis 
reported here represents a minimum estimate, because we have 
not accounted for patients presenting to community hospitals 
in the province who were not referred to Sappasithiprasong 
Hospital. There are several reasons for the lack of referral, 
including patients with mild disease and those who were seri-
ously ill and died shortly after admission to a community hos-
pital or during inter-hospital transfer. Diagnostic microbiology 
is not available in these hospitals, and it is also possible that 
the diagnosis could be missed. Melioidosis can present with 
a wide range of clinical manifestations, and our study shows 
that active use of diagnostic microbiology can improve case 
detection. It is also likely that melioidosis is underreported 
as a cause of death in the National Statistics; laboratory iso-
lation and identification of   B. pseudomallei   may take up to 
1 week, and one-half of deaths because of melioidosis occur 
in the first 48 hours after presentation to hospital when the 
true diagnosis may be unknown and not listed on the death 
certificate. 
  The death rate from melioidosis showed a modest decline 
during the study period and is currently around 40%. This 
improvement was not associated with changes in recommended 
antimicrobial regimens over the study period. Ceftazidime 
has been the recommended first-line parenteral therapy at 
Sappasithiprasong Hospital for suspected or proven melioi-
dosis after a study published in 1989 showed ceftazidime to 
be associated with a 50% overall reduction in mortality com-
pared with a combination of chloramphenicol, doxycycline, 
and trimethoprim-sulphamethoxazole.  17   Improved outcome 
from melioidosis over the study period may reflect improve-
ments in the standard of medical care provided in provin-
cial Thailand. However, the death rate of 40% is double that 
reported for patients with melioidosis at the Royal Darwin 
Hospital in Northern Australia.  7   The major cause of death 
in our melioidosis patients is severe sepsis and the associ-
ated organ failure. Most cases are not treated in an intensive-
care setting because of limited resources, and we propose that 
improvements in outcome would require investment in early 
sepsis management and critical-care facilities. Evidence for 
the efficacy of improved intensive-care unit management for 
patients with melioidosis comes from the experience described 
at the Royal Darwin Hospital.  9   There is also anecdotal evi-
dence from Khon Kaen University Hospital in neighboring 
Khon Kaen province where patients with severe melioidosis 
are treated in an intensive-care unit wherever possible and 
the mortality rate is around 20% (P. Chetchotisakd, personal 
communication). 
  There are several possible explanations for the increas-
ing rate of melioidosis over time. Our method of case ascer-
tainment did not change during the study, but most patients 
admitted to Sappasithiprasong Hospital were referred from 
community hospitals situated throughout the province; it is 
possible that referral patterns have changed over this period. 
A rise in incidence could also relate to rising life expectancy 
  Table  2 
    Average incidence rate of melioidosis by age, sex, and diabetes   






Total population 2,217 1,745,364 12.7
Sex
Female 921 875,727 10.5
Male 1,296 869,638 14.9
Age (years)
< 15 199 418,459 4.8
15–24 71 315,076 2.3
25–34 193 341,134 5.7
35–44 402 272,645 14.7
45–54 528 181,646 29.1
55–64 503 110,835 45.4
65–74 248 68,691 36.1
> 75 73 36,878 19.8
Diabetes
No diabetes 1,123 1,656,090 6.8
Known diabetes 662 45,448 145.7
Undiagnosed diabetes 370 43,826 84.4
    *     Average population in Ubon Ratchathani province for the period from 1997 to 2006.   
  Table  3 
    Crude and adjusted RR for melioidosis by age, sex, and diabetes   
Risk factor
Crude 
RR 95% CI   P   value
Adjusted 
RR 95% CI   P   value
Sex
Female 1.0 < 0.001 1.0 < 0.001
Male 1.4 1.3–1.5 1.5 1.4–1.6
Age (years)
< 45 1.0 < 0.001 1.0 < 0.001
≥ 45 4.7 4.3–5.2 2.8 2.6–3.1
Diabetes
No diabetes 1.0 < 0.001 1.0 < 0.001
Known 
diabetes
18.1 16.4–20.0 12.4 11.2–13.7
Undiagnosed 
diabetes
10.3 9.1–11.6 7.8 6.9–8.9
  Figure   1.       Mortality rates from infectious diseases per 100,000 
people in Ubon Ratchathani province between 1997 and 2006. Mor-
tality rates due to AIDS, tuberculosis, malaria and diarrhea were 
taken from the Thailand health profile report 2005–2007 from the 
Ministry of Public Health Thailand.  16     1116 LIMMATHUROTSAKUL AND OTHERS
and a concomitant increase in people with pre-disposing con-
ditions. Data available for life expectancy in Thailand between 
1998 and 2004 show a modest increase from 68.9 years in 1998 
to 70.3 years in 2004.  16   The strongest risk factor for melioido-
sis is diabetes mellitus, which was shown in this study to put 
individuals at vastly increased risk of   B. pseudomallei   infec-
tion. The prevalence of diabetes in people in Thailand seems 
to be rising over time, and the reported rates of diagnosed plus 
undiagnosed diabetes are 2.3% for 1991, 4.6% for 1996, and 
6.7% for 2004.  15,  16   The adjusted RR of melioidosis for diabe-
tes of 12.4 in this study is consistent with that reported from 
northern Australia.  6   We are not aware of any factors relating 
to changes in social behavior that would lead to an increase in 
the rate or duration of exposure to   B. pseudomallei   in the envi-
ronment, and no association was found with annual rainfall. 
Understanding the reasons behind the increasing incidence in 
melioidosis is important for targeted prevention, and it is the 
basis of on-going studies. 
  A limitation of this study is that the incidence of melioidosis 
and population mortality rates were based on active surveil-
lance at a single hospital. This provides a minimum estimate 
for a single province and may not be accurate for the rest 
of northeast Thailand. To address this, we contacted 19 pro-
vincial hospital laboratories in northeast Thailand to obtain 
data on the number of culture-confirmed cases of melioidosis 
in 2007. A total of 1,865 culture cases were defined without 
active surveillance, including 387 patients defined from Ubon 
Ratchathani provincial hospital laboratory. This is equivalent 
to an annual incidence rate for northeast Thailand of 8.7 per 
100,000 people (95% CI = 8.3–9.1 per 100,000 people), which 
is a minimum estimate that is significantly higher than the 
rate reported previously.  2   Melioidosis is known to occur in 
the areas of Laos and Cambodia that are immediately adja-
cent to northeast Thailand,  18–  20   but incidence rates are poorly 
defined and may be grossly underestimated because of a lack 
of diagnostic microbiology facilities. We predict that melioi-
dosis will become recognized as a major pathogen through-
out this region in the wake of laboratory strengthening and 
use of standard guidelines for the investigation of suspected 
melioidosis. 
  Received January 20, 2010. Accepted for publication January 24, 
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